Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Tarsus Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −1 vs. Q3 2021
- Shares held
- 13.1M
- +203.5K (+1.6%) vs. Q3 2021
- Total value
- $294.2M
- +$16.9M (+6.1%) vs. Q3 2021
- New holders
- 2
- 17 more added
- Sold out
- 3
- 8 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $2.98B |
| Q1 2026 | 253 | $3.17B |
| Q4 2025 | 246 | $3.61B |
| Q3 2025 | 220 | $2.67B |
| Q2 2025 | 205 | $1.87B |
| Q1 2025 | 195 | $2.26B |
| Q4 2024 | 195 | $2.23B |
| Q3 2024 | 162 | $1.43B |
| Q2 2024 | 148 | $1.09B |
| Q1 2024 | 157 | $1.43B |
| Q4 2023 | 116 | $652.0M |
| Q3 2023 | 105 | $529.4M |
| Q2 2023 | 92 | $387.3M |
| Q1 2023 | 74 | $252.1M |
| Q4 2022 | 69 | $301.0M |
| Q3 2022 | 75 | $350.8M |
| Q2 2022 | 73 | $291.7M |
| Q1 2022 | 51 | $222.2M |
| Q4 2021 | 43 | $294.2M |
| Q3 2021 | 44 | $277.4M |
| Q2 2021 | 44 | $378.5M |
| Q1 2021 | 41 | $410.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 2,987,331 | $67.2M | 4.05% | 00.0% | Unchanged |
| RTW Investments, LP | 2,013,601 | $45.3M | 0.66% | 00.0% | Unchanged |
| Frazier Management LLC | 1,417,157 | $31.9M | 2.45% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,403,331 | $31.6M | 1.88% | −41,500−2.9% | Reduced |
| Perceptive Advisors LLC | 1,296,416 | $29.2M | 0.45% | 00.0% | Unchanged |
| TimesSquare Capital Management, LLC | 660,800 | $14.9M | 0.13% | +10,020+1.5% | Added |
| Cowen and Company, LLC | 514,289 | $11.6M | 1.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 459,190 | $10.3M | 0.00% | +30,200+7.0% | Added |
| BlackRock Inc. | 448,958 | $10.1M | 0.00% | +7,338+1.7% | Added |
| Jefferies Group LLC | 422,993 | $9.52M | 0.18% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 260,000 | $5.85M | 0.87% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 242,451 | $5.46M | 0.01% | +42,451+21.2% | Added |
| JPMorgan Chase & Co | 174,736 | $3.93M | 0.00% | +171,499+5,298.1% | Added |
| Ghost Tree Capital, LLC | 170,000 | $3.83M | 1.46% | 00.0% | Unchanged |
| State Street Corp | 129,742 | $2.92M | 0.00% | +2,940+2.3% | Added |
| Geode Capital Management, LLC | 125,815 | $2.83M | 0.00% | +2,117+1.7% | Added |
| Northern Trust Corp | 71,781 | $1.61M | 0.00% | −2,230−3.0% | Reduced |
| Charles Schwab Investment Management Inc | 47,181 | $1.06M | 0.00% | +415+0.9% | Added |
| SG Americas Securities, LLC | 44,330 | $997.0K | 0.01% | −1,923−4.2% | Reduced |
| Goldman Sachs Group Inc | 28,103 | $632.0K | 0.00% | +1,623+6.1% | Added |
| Bank of New York Mellon Corp | 25,286 | $569.0K | 0.00% | +763+3.1% | Added |
| Nuveen Asset Management, LLC | 21,763 | $565.0K | 0.00% | 00.0% | Unchanged |
| Invesco Ltd. | 23,904 | $538.0K | 0.00% | −4,710−16.5% | Reduced |
| Allspring Global Investments Holdings, LLC | 12,885 | $289.0K | 0.00% | +12,885 | New |
| Morgan Stanley | 11,238 | $253.0K | 0.00% | −17,292−60.6% | Reduced |
| Bank of America Corp | 10,662 | $240.0K | 0.00% | +4,891+84.8% | Added |
| Dimensional Fund Advisors LP | 8,990 | $202.0K | 0.00% | +8,990 | New |
| Wells Fargo & Company | 7,654 | $172.0K | 0.00% | −2,130−21.8% | Reduced |
| New York State Common Retirement Fund | 5,872 | $132.0K | 0.00% | −9−0.2% | Reduced |
| Deutsche Bank AG | 5,687 | $128.0K | 0.00% | +270+5.0% | Added |
| California State Teachers Retirement System | 4,640 | $104.0K | 0.00% | +120+2.7% | Added |
| American International Group, Inc. | 4,480 | $101.0K | 0.00% | −134−2.9% | Reduced |
| UBS Group AG | 3,084 | $70.0K | 0.00% | +2,584+516.8% | Added |
| Royal Bank of Canada | 2,147 | $49.0K | 0.00% | +1,222+132.1% | Added |
| Citigroup Inc | 2,145 | $48.0K | 0.00% | +1,183+123.0% | Added |
| STRS Ohio | 2,100 | $47.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 818 | $19.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 652 | $14.0K | 0.00% | +187+40.2% | Added |
| Ameritas Investment Partners, Inc. | 515 | $12.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $5.00K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 100 | $2.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 39 | $878 | 0.00% | 00.0% | Unchanged |
| Tucker Asset Management LLC | 4 | $96 | 0.00% | 00.0% | Unchanged |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −22,198−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −6,008−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |